Higher cancer rates found in military pilots, ground crews
WASHINGTON — A Pentagon study has found high rates of cancer among military pilots and…
Category: Biotech
Virtual Event: Can Tech Fix Primary Care?
Editor’s note: A livestream on the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Manufacturers say bird flu shots for humans can be made quickly; obesity guidelines for children disappoint
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
An AI medical scribe platform is the latest entrant into the AI arms race. On…
STAT+: Karuna’s treatment for schizophrenia achieves study goals, bolsters FDA filing plans
Karuna Therapeutics said Monday that its treatment for schizophrenia reduced psychosis reported by patients —…
Watch: P-value, an important measurement in clinical trials, explained
When testing new treatments, drugmakers must show that their formulation bears out better results than…
Opinion: Will there be any emergency doctors to see you in the future?
In the emergency room today, everyone is suffering. Many emergency medicine physicians are struggling to…
STAT+: Hospitals are not crumbling, Medicare experts tell Congress
Hospitals’ financial situations are not nearly as dire as industry groups are making them out…
.jpg)
‘That scares me’: New childhood obesity guidelines still face a long road to consensus
This is part of a series about new obesity drugs that are transforming patients’ lives,…
‘A safe place to fail’: ARPA-H chief on building a culture of risk-taking in science
Renee Wegrzyn has been assembling teams her whole career — in academia, industry, and government….
.jpg)
STAT+: Takeda autoimmune therapy shows effectiveness in key trial
Doctors and investors are getting their first glimpse of the data that compelled Takeda Pharmaceutical…
‘I’m terrified’: Patients scramble for treatment after 13 ketamine clinics shut down
Around 4:30 p.m. last Friday, Ketamine Wellness Centers CEO Kevin Nicholson sent an email: In…
STAT+: Moderna CEO made $398 million in 2022, but still pledges to give most to charity
Moderna CEO Stéphane Bancel is starting to reap gargantuan gains from the stock he first…
STAT+: Pharmalittle: Sanofi cuts price on a popular insulin by 78%; Califf criticizes insurers for doing too little on drug research
And so, another working week will soon draw to a close. Not a moment too…
JAMA’s new editor settles in, bringing open access and other changes
ST. LOUIS — It’s been eight months since Kirsten Bibbins-Domingo, a general internist, cardiovascular researcher,…
STAT+: To prevent emergency C-sections, researchers turn to AI to predict the course of childbirth
After more than a decade as an OB-GYN, Darine El-Chaâr still finds late-stage emergency C-sections…
Opinion: The staggering financial burden of a proposed HIPAA rule
The already beleaguered U.S. health care system is facing a new and costly threat that…
Polio cases derived from new oral vaccine reported for first time
Experts have long understood that a new polio vaccine developed to try to minimize the…
STAT+: Federal Medicaid officials cajole states to auto-enroll beneficiaries as huge coverage losses loom
WASHINGTON — Federal Medicaid officials are working unusually closely with states to avoid enrollment glitches…
STAT+: FDA to convene advisory panel for Sarepta’s gene therapy for Duchenne
In a sudden about-face, the Food and Drug Administration will hold a meeting of outside…
STAT+: Sanofi becomes the third leading insulin maker to lower list prices, cutting Lantus price by 78%
Following the lead of its rivals, Sanofi will cut the price of its most widely…
Listen: SVB’s long biotech shadow, pushy AI algorithms, & Icahn v. Illumina
Is AI dictating patient care? What happens when your bank falls apart? And can Illumina…
STAT+: Here’s why there aren’t many cheap, generic versions of pricey inhalers
U.S. regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over…
STAT+: Califf criticizes insurers for doing too little on drug research
WASHINGTON — FDA Commissioner Robert Califf wants private insurers to chip in on doing post-approval…
U.S. pregnancy deaths dropped in 2022, after Covid spike
NEW YORK — Deaths of pregnant women in the U.S. fell in 2022, dropping significantly…
Large network of clinics offering ketamine for depression shuts down
One of the largest operators of ketamine clinics in the country abruptly closed its facilities…
STAT+: Pharmalittle: Alzheimer’s group starts lobbying for Medicare to cover new drug; U.S. judge seems sympathetic to abortion-pill challenge
Good morning, everyone, and how are you today? Hazy skies are enveloping the frosty Pharmalot…
STAT+: U.K. trade group suspends Novo Nordisk for ‘serious breaches’ in promoting obesity drug
In a rare move, a U.K. pharmaceutical industry trade group suspended Novo Nordisk for two…
STAT+: CRISPR? Nah. A new startup bets on an old approach to gene editing
Before there was CRISPR, aspiring genome editors relied on an island of misfit, less elegantly…
FDA offers radio silence on question of spring Covid boosters, as other countries push ahead
Are you six months out from your Covid-19 bivalent booster and wondering when you’ll be…
‘That is my dream’: Scientist who uncovered likely leading cause of MS wants to tackle ALS next
Alberto Ascherio began his career as a young doctor treating tropical diseases in South American…
STAT+: Momentum grows to subject medical devices to medicine’s gold standard — the placebo treatment
It’s the gold standard in medicine: taking a treatment, and putting it head-to-head against a…
STAT+: The big-money Medicare policy that has hospitals worried this Congress
WASHINGTON — There are few things that get lawmakers in Washington salivating more than a wonky…
Opinion: The Cancer Moonshot will never take off without economists and finance experts
In February, President Biden announced the reboot of the Cancer Moonshot and vowed to reduce…
STAT+: Medicare explains how it will choose drugs for negotiation
WASHINGTON — Medicare laid out Thursday in the greatest detail yet how it will choose…
STAT+: Would the federal government defer to states to regulate PBMs?
WASHINGTON — After years of struggling to regulate the drug middlemen that create pharmacy networks,…
Conservative Texas judge weighs challenge to abortion pill
AMARILLO, Texas — A conservative federal judge in Texas heard arguments Wednesday from a Christian group…
Opinion: Listen: Big changes for First Opinion
After two years as host of the “First Opinion Podcast” and many more as the…
STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: White House chooses a location for ARPA-H — sort of
WASHINGTON — Officials at the Advanced Research Projects Agency for Health are moving ahead with…
STAT+: Biden administration to fine manufacturers of 27 medicines for price hikes
WASHINGTON — The Biden administration will fine drugmakers who hiked prices faster than the rate…
West Nile, Lyme, and other diseases are on the rise with climate change. Experts warn the U.S. is not prepared
In the summer and fall of 2021, West Nile virus spread rapidly through Arizona’s Maricopa…
Opinion: AI chatbots can improve health — but only with help from humans
Chatbots like OpenAI’s ChatGPT can hold fun conversations across many topics. But when it comes…
STAT+: In Minnesota, researchers explore how to audit health AI models on a patient level
As hospitals and companies continue to leverage artificial intelligence in medicine, researchers are also grappling…
Opinion: Drug developers navigating ‘biology’s century’ need a model. We made one
STAT’s Matthew Herper struck an industry nerve when he wrote that the drug development industry…
STAT+: Democratic lawmakers press pharmacy chains on abortion pill access
More than a dozen Democratic lawmakers are urging some of the nation’s largest drugstore chains…
STAT+: PhRMA chief dings health insurers over drug prices at their own conference
WASHINGTON — The head of the brand drug lobby used an in-person health insurance industry…
A letter from the executive editor: The 2023 STATUS List
After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the…
National Academies calls for transforming use of racial and ethnic labels in genetics research
Saying genetics researchers inconsistently and inappropriately use racial and ethnic labels that fail to capture…
STAT+: Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA
Behind the stellar commercial launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question:…